form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
June 24, 2010
(Date of earliest event reported)
LABORATORY CORPORATION OF
AMERICA HOLDINGS
(Exact Name of Registrant as Specified in its Charter)
|
Delaware
|
|
1-11353
|
|
13-3757370
|
|
(State or other jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
358 South Main Street,
|
|
|
|
|
|
Burlington, North Carolina
|
|
27215
|
|
336-229-1127
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
(Registrant’s telephone number including area code)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
[ ]
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 7.01
|
Regulation FD Disclosure
|
On June 16, 2010 LabCorp acquired certain assets of Westcliff Medical Laboratories and related entities (“Westcliff”), which operate a clinical laboratory testing business in the State of California, pursuant to an Asset Purchase Agreement dated May 17,2010 and an Order of the Bankruptcy Court administering the bankruptcy of Westcliff. The Company was notified by the Federal Trade Commission that the FTC intended to review the acquisition and on June 24, 2010, the Company entered into an agreement with the FTC to hold the Westcliff business as an independent laboratory, separate and apart from LabCorp while the FTC conducts its review of the transaction. LabCorp is working with the FTC to complete the review as quickly as possible but the Company is presently unable to determine the time frame for conclusion of the FTC’s review.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Registrant
| |
By:
|
/s/ F. SAMUEL EBERTS III
|
| |
|
F. Samuel Eberts III
|
| |
|
Chief Legal Officer and Secretary
|
July 1, 2010